Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis

Clinical trial NCT00249002 · TERMINATED

Trial details

NCT number: NCT00249002
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hemodialysis Graft Dysfunction

Start date: 2005-11-01
Primary completion: 2007-11-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.